These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 18549667)

  • 21. Optimization of propranolol hydrochloride sustained-release pellets using box-behnken design and desirability function.
    Bodea A; Leucuta SE
    Drug Dev Ind Pharm; 1998 Feb; 24(2):145-55. PubMed ID: 15605444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.
    Corti G; Cirri M; Maestrelli F; Mennini N; Mura P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):303-9. PubMed ID: 17616379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo evaluation of ofloxacin sustained release pellets.
    Cui Y; Zhang Y; Tang X
    Int J Pharm; 2008 Aug; 360(1-2):47-52. PubMed ID: 18538518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations.
    Tajiri S; Kanamaru T; Kamada M; Konno T; Nakagami H
    Int J Pharm; 2010 Jan; 383(1-2):99-105. PubMed ID: 19747964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of implant tablet for a week-long sustained release.
    Takahashi M; Onishi H; Machida Y
    J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.
    Basak SC; Rahman J; Ramalingam M
    Pharmazie; 2007 Feb; 62(2):145-8. PubMed ID: 17341036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs.
    Löbenberg R; Kim JS; Amidon GL
    Eur J Pharm Biopharm; 2005 May; 60(1):17-23. PubMed ID: 15848051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery.
    Strübing S; Metz H; Mäder K
    Eur J Pharm Biopharm; 2007 Apr; 66(1):113-9. PubMed ID: 17101269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.
    Vijayaraghavan C; Vasanthakumar S; Ramakrishnan A
    Pharmazie; 2008 May; 63(5):342-7. PubMed ID: 18557416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of a Time-Controlled Pulsatile Release System for Propranolol Using the Dry-Coated Method: In Vitro and In Vivo Evaluation.
    Chen K; Wang Y; Gai X; Wang H; Li Y; Wen H; Pan W; Yang X
    AAPS PharmSciTech; 2017 Oct; 18(7):2683-2690. PubMed ID: 28281210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations.
    Halsas M; Penttinen T; Veski P; Jürjenson H; Marvola M
    Pharmazie; 2001 Sep; 56(9):718-23. PubMed ID: 11593992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo evaluation of a matrix-in-cylinder system for sustained drug delivery.
    Mehuys E; Vervaet C; Gielen I; Van Bree H; Remon JP
    J Control Release; 2004 Apr; 96(2):261-71. PubMed ID: 15081217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma.
    Barakat NS; Al-Suwayeh SA; Taha EI; Bakry Yassin AE
    J Drug Target; 2011 Jun; 19(5):365-72. PubMed ID: 20681754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of a novel diltiazem hydrochloride polydispersity sustained-release system.
    Sun C; Liu H; Zhao X; He H; Pan W
    Drug Dev Ind Pharm; 2013 Jan; 39(1):62-6. PubMed ID: 22339081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The study of the in vivo-in vitro correlation of the naftopidil sustained-release tablet in dog].
    Jia Y; Jiang X; Ding J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):826-8, 843. PubMed ID: 17002117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
    Leucuta SE
    Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
    Chen SJ; Zhu JB
    Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparation and examination of the vitro releasing of pH-dependent kuijiekang tablet for colon-specific delivery].
    Li RZ; Liao HW; Chen FY
    Zhong Yao Cai; 2007 Aug; 30(8):1025-7. PubMed ID: 18074860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.